Home › Funds › Eversept Partners, LP › INSM

Eversept Partners, LP position in INSM

INSMED INC · Health Care

Eversept Partners, LP reported holding 96,600 shares of INSM (INSMED INC) in its Q2 2026 13F filing — a position valued at US$10.3M, representing 0.54% of its reported portfolio and ranking #47 among its reported holdings. Eversept Partners, LP has disclosed INSM holdings in 4 of the last 9 reported quarters, going back to Q2 2024.

Latest position (Q2 2026)96.60K sh
Reported value held$10.30M
Portfolio Weight0.54%
First reportedQ2 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Eversept Partners, LP's INSM position evolved

Eversept Partners, LP first disclosed a stake in INSM in Q2 2024 at 1,155,588 shares (US$77.4M). The position peaked in Q3 2024 at 1,089,404 shares, worth US$79.5M. Across 4 filings, Eversept Partners, LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 96,600 shares valued at US$10.3M — an increase of 2,600 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2024 1.16M $77.42M New
Q3 2024 1.09M $79.53M Reduce
Q1 2026 94.00K $15.37M New
Q2 2026 96.60K $10.30M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About INSM and 13F data

INSM (INSMED INC) is a Health Care company. 40 other funds we track also report a position in INSM — the largest reported positions include BAKER BROS. ADVISORS LP (US$937.8M), Darwin Global Management, Ltd. (US$673.6M), Orbis Allan Gray Ltd (US$647.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding INSM

All INSM fund holders →

FAQ

How long has Eversept Partners, LP held INSM?

Eversept Partners, LP has disclosed INSM holdings in 4 of the last 9 reported quarters, going back to Q2 2024.

What is Eversept Partners, LP's current position in INSM?

As of Q2 2026, Eversept Partners, LP holds 96.60K shares of INSM (INSMED INC), valued at $10.30M, representing 0.54% of its reported portfolio and ranking #47.

Has Eversept Partners, LP been buying or selling INSM?

In the latest 13F filing (Q2 2026), Eversept Partners, LP increased its position in INSM. The position peaked in Q3 2024 at 1.09M shares.

Which other funds hold INSM?

Other major institutional holders of INSM include BAKER BROS. ADVISORS LP, Darwin Global Management, Ltd., Orbis Allan Gray Ltd, among 40 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.